These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 27220593)

  • 1. Pulmonary Artery Pressure-Guided Heart Failure Management Reduces 30-Day Readmissions.
    Adamson PB; Abraham WT; Stevenson LW; Desai AS; Lindenfeld J; Bourge RC; Bauman J
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27220593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.
    Adamson PB; Abraham WT; Bourge RC; Costanzo MR; Hasan A; Yadav C; Henderson J; Cowart P; Stevenson LW
    Circ Heart Fail; 2014 Nov; 7(6):935-44. PubMed ID: 25286913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
    J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
    Costanzo MR; Stevenson LW; Adamson PB; Desai AS; Heywood JT; Bourge RC; Bauman J; Abraham WT
    JACC Heart Fail; 2016 May; 4(5):333-44. PubMed ID: 26874388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).
    Angermann CE; Assmus B; Anker SD; Brachmann J; Ertl G; Köhler F; Rosenkranz S; Tschöpe C; Adamson PB; Böhm M
    Clin Res Cardiol; 2018 Nov; 107(11):991-1002. PubMed ID: 29777373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system.
    Adamson PB; Abraham WT; Aaron M; Aranda JM; Bourge RC; Smith A; Stevenson LW; Bauman JG; Yadav JS
    J Card Fail; 2011 Jan; 17(1):3-10. PubMed ID: 21187258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial.
    Abraham WT; Stevenson LW; Bourge RC; Lindenfeld JA; Bauman JG; Adamson PB;
    Lancet; 2016 Jan; 387(10017):453-61. PubMed ID: 26560249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy.
    Varma N; Bourge RC; Stevenson LW; Costanzo MR; Shavelle D; Adamson PB; Ginn G; Henderson J; Abraham WT;
    J Am Heart Assoc; 2021 Feb; 10(5):e017619. PubMed ID: 33626889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study.
    Shavelle DM; Desai AS; Abraham WT; Bourge RC; Raval N; Rathman LD; Heywood JT; Jermyn RA; Pelzel J; Jonsson OT; Costanzo MR; Henderson JD; Brett ME; Adamson PB; Stevenson LW;
    Circ Heart Fail; 2020 Aug; 13(8):e006863. PubMed ID: 32757642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor.
    Heywood JT; Jermyn R; Shavelle D; Abraham WT; Bhimaraj A; Bhatt K; Sheikh F; Eichorn E; Lamba S; Bharmi R; Agarwal R; Kumar C; Stevenson LW
    Circulation; 2017 Apr; 135(16):1509-1517. PubMed ID: 28219895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Ambulatory Hemodynamic Monitoring of Heart Failure With Clinical Outcomes in a Concurrent Matched Cohort Analysis.
    Abraham J; Bharmi R; Jonsson O; Oliveira GH; Artis A; Valika A; Capodilupo R; Adamson PB; Roberts G; Dalal N; Desai AS; Benza RL
    JAMA Cardiol; 2019 Jun; 4(6):556-563. PubMed ID: 31090869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
    Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CardioMEMS system in the clinical management of end-stage heart failure patients: three case reports.
    Tschöpe C; Alogna A; Spillmann F; Faragli A; Schmidt G; Blaschke F; Kühl U; Hertel E; Willner M; Morris D; Post H; Noutsias M; Pieske B; Krackhardt F
    BMC Cardiovasc Disord; 2018 Jul; 18(1):155. PubMed ID: 30064356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.
    Abraham WT; Adamson PB; Bourge RC; Aaron MF; Costanzo MR; Stevenson LW; Strickland W; Neelagaru S; Raval N; Krueger S; Weiner S; Shavelle D; Jeffries B; Yadav JS;
    Lancet; 2011 Feb; 377(9766):658-66. PubMed ID: 21315441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure management with ambulatory pulmonary artery pressure monitoring.
    Sandhu AT; Heidenreich PA
    Trends Cardiovasc Med; 2018 Apr; 28(3):212-219. PubMed ID: 28988604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
    Lindenfeld J; Zile MR; Desai AS; Bhatt K; Ducharme A; Horstmanshof D; Krim SR; Maisel A; Mehra MR; Paul S; Sears SF; Sauer AJ; Smart F; Zughaib M; Castaneda P; Kelly J; Johnson N; Sood P; Ginn G; Henderson J; Adamson PB; Costanzo MR
    Lancet; 2021 Sep; 398(10304):991-1001. PubMed ID: 34461042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device.
    Krahnke JS; Abraham WT; Adamson PB; Bourge RC; Bauman J; Ginn G; Martinez FJ; Criner GJ;
    J Card Fail; 2015 Mar; 21(3):240-9. PubMed ID: 25541376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote Hemodynamic Monitoring Equally Reduces Heart Failure Hospitalizations in Women and Men in Clinical Practice: A Sex-Specific Analysis of the CardioMEMS Post-Approval Study.
    DeFilippis EM; Henderson J; Axsom KM; Costanzo MR; Adamson PB; Miller AB; Brett ME; Givertz MM
    Circ Heart Fail; 2021 Jun; 14(6):e007892. PubMed ID: 34129363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in "Real-World" Clinical Practice.
    Desai AS; Bhimaraj A; Bharmi R; Jermyn R; Bhatt K; Shavelle D; Redfield MM; Hull R; Pelzel J; Davis K; Dalal N; Adamson PB; Heywood JT
    J Am Coll Cardiol; 2017 May; 69(19):2357-2365. PubMed ID: 28330751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the CardioMEMS pulmonary artery pressure sensor.
    Ayyadurai P; Alkhawam H; Saad M; Al-Sadawi MA; Shah NN; Kosmas CE; Vittorio TJ
    Ther Adv Cardiovasc Dis; 2019; 13():1753944719826826. PubMed ID: 30803405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.